Retinal and lens protective effect of sitagliptin in streptozotocin induced type-I diabetic wistar rats

Biomedicine and Aging Pathology

Volumn 3, Issue 2, 2013, Pages 65-73

  Pandit, Rahul S ^a   Kelkar, Aditya S ^b   Bodhankar, Subhash L ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b National Institute of Ophthalmology   (India)

Author keywords

Advanced glycation end products; Cataract; Diabetic retinopathy; Fundoscopy; Glycated hemoglobin; Sitagliptin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; HEMOGLOBIN A1C; SITAGLIPTIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CATARACT; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EYE EXAMINATION; EYE PROTECTION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LENS; MALE; NONHUMAN; OPHTHALMOSCOPY; PANCREAS; PRIORITY JOURNAL; RAT; RETINA; RETINA INJURY; SLIT LAMP; STREPTOZOCIN DIABETES; TISSUE NECROSIS;

EID: 84880134733     PISSN: 22105220     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomag.2013.04.002     Document Type: Article

References (23)

1. A.D. Kandhare, K.S. Raygude, P. Ghosh, A.E. Ghule, and S.L. Bodhankar Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy Fitoterapia 83 2012 650 659
2. M.D. Davis Diabetic retinopathy: a clinical overview Diabetes Care 15 1992 1844 1874
3. R.N. Frank Diabetic retinopathy N Engl J Med 350 2004 48 58
4. P. Ghosh, A.D. Kandhare, K.S. Raygude, V.S. Kumar, A.R. Rajmane, and M. Adil Determination of the long-term diabetes related complications and cardiovascular events using UKPDS risk engine and UKPDS outcomes model in a representative western Indian population Asian Pac J Trop Dis 2 2012 S642 S650
5. A.D. Kandhare, K.S. Raygude, V. Shiva Kumar, A.R. Rajmane, A. Visnagri, and A.E. Ghule Ameliorative effects quercetin against impaired motor nerve function, inflammatory mediators and apoptosis in neonatal streptozotocin- induced diabetic neuropathy in rats Biomed Aging Pathol 2 2012 173 186
6. B. Charbonnel, A. Karasik, J. Liu, M. Wu, and G. Meininger Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone Diabetes Care 29 2006 2638 2643
7. J. Rosenstock, R. Brazg, P.J. Andryuk, K. Lu, and P. Stein Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study Clin Ther 28 2006 1556 1568
8. A.D. Kandhare, K.S. Raygude, P. Ghosh, T.P. Gosavi, and S.L. Bodhankar Patentability of animal models: India and the globe Int J Pharm Biol Arch 2 2011 1024 1032
9. A. Behndig, K. Karlsson, T. Brannstrom, M.L. Sentman, and S.L. Marklund Corneal endothelial integrity in mice lacking extracellular superoxide dismutase Invest Ophthalmol Vis Sci 42 2001 2784 2788
10. R.N. Frank Diabetic retinopathy New Engl J Med 350 2004 2525 2526
11. D.J. Drucker, and M.A. Nauck The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 2006 1696 1705
12. E. Bosi Time for testing incretin therapies in early type 1 diabetes? J Clin Endocrinol Metab 95 2010 2607 2609
13. A. Visnagri, A.D. Kandhare, V. Shiva Kumar, A.R. Rajmane, A. Mohammad, and P. Ghosh Elucidation of ameliorative effect of Co-enzyme Q10 in streptozotocin-induced diabetic neuropathic perturbation by modulation of electrophysiological, biochemical and behavioral markers Biomed Aging Pathol 2 2012 157 172
14. K. Yanagisawa, Z. Makita, K. Shiroshita, T. Ueda, T. Fusegawa, and S. Kuwajima Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients Metabolism 47 1998 1348 1353
15. H.E.M. Ali Hussain Reversal of diabetic retinopathy in streptozotocin induced diabetic rats using traditional Indian anti-diabetic plant, azadirachta indica (L.) Indian J Clin Biochem 17 2002 115 123
16. A.J. Barber, E. Lieth, S.A. Khin, D.A. Antonetti, A.G. Buchanan, and T.W. Gardner Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin J Clin Invest 102 1998 783
17. N. Kato, S. Yashima, T. Suzuki, Y. Nakayama, and T. Jomori Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats J Diabetes Complications 17 2003 374 379
18. K. Kohzaki, A.J. Vingrys, and B.V. Bui Early inner retinal dysfunction in streptozotocin-induced diabetic rats Invest Ophthalmol Vis Sci 49 2008 3595 3604
19. P.M. Martin, P. Roon, T.K. Van Ells, V. Ganapathy, and S.B. Smith Death of retinal neurons in streptozotocin-induced diabetic mice Invest Ophthalmol Vis Sci 45 2004 3330 3336
20. I. Obrosova, V. Drel, A. Kumagai, C. Szabo, P. Pacher, and M. Stevens Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models Diabetologia 49 2006 2525 2533
21. Y. Jing, N. Ma, T. Fan, C. Wang, X. Bu, and G. Jiang Tumor necrosis factor-alpha promotes tumor growth by inducing vascular endothelial growth factor Cancer Invest 29 2011 485 493
22. N. Ogata, M. Nishikawa, T. Nishimura, Y. Mitsuma, and M. Matsumura Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy Am J Ophthalmol 134 2002 348 353
23. A.C. Powers, and D. D'alessio Endocrine pancreas and pharmacotherapy of diabetes mellitus and hypoglycemia Goodman Gilman: Pharmacol Basis Ther 11 2011 1250 1270